Polymeric particles for sustained and local drug delivery

Keyphrases

• Poly(lactic-co-glycolic acid) 100%
• Polymer Particles 100%
• Local Drug Delivery 100%
• Sustained Drug Release 100%
• Sunitinib 75%
• Particulate Systems 75%
• Polyethylene Glycol 50%
• Drug Concentration 50%
• Drug Delivery System 50%
• Controlled Drug Delivery 50%
• Organ Tissue 50%
• Amphiphilic Drug 50%
• Poly(lactic-co-glycolic acid) Microspheres 50%
• Lung 25%
• Efflux Pump 25%
• Small Molecules 25%
• Preparation Method 25%
• Nanoparticles 25%
• Drug Loading 25%
• Cancer Types 25%
• Product Basis 25%
• Biodegradable Polyesters 25%
• Polymer Blends 25%
• Untargeted 25%
• Physicochemical Properties 25%
• Poly(lactic-co-glycolic acid) Nanoparticles 25%
• Low Molecular Weight 25%
• Angiogenesis 25%
• Imatinib 25%
• Liver 25%
• Therapeutic Proteins 25%
• Amphiphilic Molecules 25%
• Controlled Release 25%
• Emulsification Method 25%
• Microparticles 25%
• Semi-crystalline 25%
• Extended Period 25%
• Chitosan-coated 25%
• Copolymer 25%
• Release Kinetics 25%
• Polymeric Materials 25%
• Ophthalmic Diseases 25%
• Poly(D,L-lactide) 25%
• In Vitro Release 25%
• Antiangiogenic 25%
• Chick Chorioallantoic Membrane Assay 25%
• Polymeric Drugs 25%
• Drug Availability 25%
• Small Hydrophilic Molecules 25%
• Peritoneum 25%
• Multi-targeted Tyrosine Kinase Inhibitors 25%
• Sustained Delivery 25%
• Local Delivery 25%
• Polymer Microspheres 25%
• Emulsion Method 25%
• Multiblock Copolymer 25%
• Poly(L-lactide) 25%
• Biodegradable Aliphatic Polyesters 25%
• Conjunctival Epithelium 25%
• Ocular Retention 25%
• Anterior Eye Segment 25%
• Ocular Barriers 25%
• Topical Instillation 25%
• Rabbit Eye 25%
• Blood-aqueous Barrier 25%
• Posterior Eye Segment 25%
• Tear Film 25%
• Drug Distribution 25%
• Drug Depot 25%
• Corneal Epithelium 25%
• Hydrophilic Drug 25%
• Ganciclovir 25%
• Therapeutic Levels 25%
• Systems-based 25%
• Small Molecule Drugs 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Microsphere 100%
• Polyglactin 87%
• Drug Delivery System 37%
• Sunitinib 37%
• Drug Concentration 25%
• Copolymer 25%
• Macrogol 25%
• Macrogol Derivative 25%
• Nanoparticle 25%
• Controlled Substance 25%
• Leporidae 12%
• Antiangiogenic 12%
• Controlled Release 12%
• Microparticle 12%
• Drug Distribution 12%
• Protein Tyrosine Kinase Inhibitor 12%
• Malignant Neoplasm 12%
• Effusion 12%
• Polymer 12%
• Agents Acting on the Eye 12%
• Chitosan 12%
• Imatinib 12%
• Ganciclovir 12%
• Localized Drug Delivery 12%
• Diseases 12%